Welcome to the Department of Biomedical Sciences

The Department is dedicated to the mission of the University through excellence in teaching, preeminence in scholarship and research, and a commitment to effective leadership in professional service in an inclusive environment. These goals are achieved through: daily contact with professional and graduate students involving didactic lectures, group interactions, and individual mentoring; significant contributions to science through innovative research; and, leadership roles in professional activities within the University, among local and state agencies, and at the National/International level in … continue reading

Graduate Studies


It is my pleasure to introduce you to the Department of Biomedical Sciences Graduate Program. With world-class and award-winning researchers, our program has a great deal to offer you! At the Department of Biomedical Sciences, investigators are engaged in research across a variety of fields, including cancer, neurodegenerative disease, exercise, cardiovascular, gastrointestinal, respiratory and reproductive physiology… continue reading

January 21

D Cornelison, Ph.D., Professor, Division of Biological Sciences, and Investigator, Bond Life Sciences Center
“The Community (Eph)ect: New molecules for a classical observation”

See full schedule and details

November 2020 Publications

1. Tongue and hypoglossal morphology after intralingual CTB-saporin injection.
Lind LA, Lever TE, Nichols NL.
Muscle Nerve. 2020 Dec 2. doi: 10.1002/mus.27131.
PMID: 33269488
2. Disruption of global hypothalamic microRNA (miR) profiles and associated behavioral changes in California mice (Peromyscus californicus) developmentally exposed to endocrine disrupting chemicals.
Kaur S, Kinkade JA, Green MT, Martin RE, Willemse TE, Bivens NJ, Schenk AK, Helferich WG, Trainor BC, Fass J, Settles M, Mao J, Rosenfeld CS.
Horm Behav. 2020 Nov 30;128:104890. doi: 10.1016/j.yhbeh.2020.104890.
PMID: 33221288
3. β2-Adrenergic Receptors Increase Cardiac Fibroblast Proliferation Through the Gαs/ERK1/2-Dependent Secretion of Interleukin-6.
Tanner MA, Thomas TP, Maitz CA, Grisanti LA.
Int J Mol Sci. 2020 Nov 12;21(22):8507. doi: 10.3390/ijms21228507.
PMID: 33198112
4. The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion.
Sukhanov S, Higashi Y, Yoshida T, Mummidi S, Aroor AR, Jeffrey Russell J, Bender SB, DeMarco VG, Chandrasekar B.
Cell Signal. 2021 Jan;77:109825. doi: 10.1016/j.cellsig.2020.109825. Epub 2020 Nov 4.
PMID: 33160017
5. Alpha adrenergic receptor signaling in the hypothalamic paraventricular nucleus is diminished by the chronic intermittent hypoxia model of sleep apnea.
Domingos-Souza G, Martinez D, Sinkler S, Heesch CM, Kline DD.
Exp Neurol. 2020 Oct 23;335:113517. doi: 10.1016/j.expneurol.2020.113517.
PMID: 33132201